Tokyo, July 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058225) titled 'A study on the actual state of IgA nephropathy patients from urinalysis abnormalities in health checkups to diagnosis and treatment using health checkup data and health insurance claims data in Japan' on July 1.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd.
Condition:
Condition - IgA nephropathy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the period and process from the urinalysis abnormalities in health checkups before diagnosis to diagnosis and the actual treatment state before and after diagnosis in IgA nep...